Controlling the STING pathway to improve immunotherapy
Crossref DOI link: https://doi.org/10.1038/s41565-024-01637-x
Published Online: 2024-03-25
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wilson, John T. http://orcid.org/0000-0002-9144-2634
Text and Data Mining valid from 2024-03-25
Version of Record valid from 2024-03-25
Article History
First Online: 25 March 2024
Competing interests
: J.T.W. holds patents and has filed patent applications on technologies for delivery of STING agonists.